demonstrated that GLP-1 agonist administration could lead to an increase in neurogenesis in the hippocampus dentate gyrus region, and demonstrated an improvement in mood and cognitive function through the swim test in adult rodents (Isacson et al., 2011)
Semaglutide is a similar hormone 'glucagon-like peptide (GLP)-1' that helps control blood sugar and suppress appetite, and was developed by Danish pharmaceutical company Novo Nordisk in 2012
To validate our findings at the site of infection, we next performed a bulk RNA-sequencing (RNA-seq) analysis of cells from bronchoalveolar lavage fluid (BALF) that was isolated from patients with severe COVID-19 and patients with influenza
Nakanishi M, Nomura J, Ji X, Tamada K, Arai T, Takahashi E, et al
The upsurge of very-low-density lipoprotein particles seems to be the core atherogenic dyslipidemia in T2DM, which is partially secondary to insulin resistance [26]